摘要
目的探讨晚期去势抵抗性前列腺癌安全、有效的治疗方法。方法以比卡鲁胺作为二线抗雄激素药物,联合多西紫杉醇加泼尼松化疗治疗26例去势抵抗性前列腺癌患者,观察疗效及毒副反应。结果 26例去势抵抗性前列腺癌患者25例有效,有效率为96.15%。最常见的毒副反应是骨髓抑制,可耐受。结论比卡鲁胺作为二线抗雄激素药物联合多西紫杉醇加泼尼松化疗治疗去势抵抗性前列腺癌的临床疗效明显,毒副反应轻,可作为晚期去势抵抗性前列腺癌的治疗策略。
Objective To explore the safe,effective treatment for castration resistant prostate cancer.Methods 26 cases with castration resistant prostate cancer enrolled in this study.All patients adopted bicalutamide as secondary anti-androgens and combined with chemotherapy of docetaxel plus prednisone acetate,and their efficacy and side effects evaluated.Results After therapy,25 patients in 26 cases with castration resistant prostate cancer were effective.The main toxicities were well-tolerated arrest of bone marrow.Conclusions The treatment of bicalutamide as secondary anti-androgens combined with the chemotherapy of docetaxel plus prednisone acetate is effective and well-tolerated for castration resistant prostate cancer patients.
出处
《现代泌尿生殖肿瘤杂志》
2011年第6期338-340,共3页
Journal of Contemporary Urologic and Reproductive Oncology